HASBROUCK HEIGHTS, N.J., June 7, 2010 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) announced today that Paul Averback, MD, DABP, President and Chief Executive Officer of Nymox, will be providing a corporate summary and a presentation regarding the Company's ongoing clinical program for NX-1207 at the Jefferies 2010 Global Life Sciences Conference in New York on June 9, 2010 at 4:30 p.m. Eastern Time.
